Rationale for a Primary Prevention Study Using Low‐Dose Aspirin To Prevent Coronary and Cerebrovascular Disease in the Elderly

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-5415|39|5|484-491

ISSN： 0002-8614

Source： JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol.39, Iss.5, 1991-05, pp. : 484-491

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Upper Gastrointestinal Symptoms Experienced by Users of Low-Dose Aspirin (Acetylsalicylic Acid) [75-325 mg/day] for Primary and Secondary Coronary Artery Disease Prevention: Perspectives from Patient Focus Groups

By >

The Patient: Patient-Centered Outcomes Research, Vol. 2, Iss. 2, 2009-06 ,pp. : 89-93

Adis International

Access to resources Recommend Favorite

The dose of aspirin for the prevention of cardiovascular and cerebrovascular events

By Fisher Matt Knappertz Volker

Current Medical Research and Opinion, Vol. 22, Iss. 7, 2006-07 ,pp. : 1239-1248

Informa Healthcare

Access to resources Recommend Favorite

Absorption kinetics of low‐dose chewable aspirin – implications for acute coronary syndromes

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 45, Iss. 1, 2015-01 ,pp. : 13-17

John Wiley & Sons Inc

Access to resources Recommend Favorite

Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment

By Lanas Angel Scheiman James

Current Medical Research and Opinion, Vol. 23, Iss. 1, 2007-01 ,pp. : 163-173

Informa Healthcare

Access to resources Recommend Favorite

Comment and reply on: The dose of aspirin for the prevention of cardiovascular and cerebrovascular events

By Serebruany Victor Fisher Matt Knappertz Volker

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1669-1670

Informa Healthcare

Access to resources Recommend Favorite